Back to User profile » Dr Shangli Cai

Papers published by Dr Shangli Cai:

Original Research

Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics

Li N, Feng Y, Lu HF, Cai SL, Zhuo JM, Si TM, Zhang LL

Neuropsychiatric Disease and Treatment 2018, 14:825-837

Published Date: 22 March 2018

Original Research

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study

Zhao JP, Li LH, Shi JG, Li Y, Xu XF, Li KQ, Zhang LL, Cai SL, Feng Y, Zhuo JM, Liu WH, Lu HF

Neuropsychiatric Disease and Treatment 2017, 13:2045-2056

Published Date: 2 August 2017

Original Research

Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication

Yang FD, Li J, Tan YL, Liang WY, Zhang R, Wang N, Feng W, Cai S, Zhuo JM, Zhang LL

Neuropsychiatric Disease and Treatment 2017, 13:1089-1097

Published Date: 13 April 2017

Original Research

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials

Cai SL, Lu HF, Bai ZH, Wu RR, Zhao JP

Neuropsychiatric Disease and Treatment 2015, 11:1817-1834

Published Date: 23 July 2015